Home > Products > Pharmaceutical R&D Materials > Heterocyclic Building Blocks > 5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-ylacetate
5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-ylacetate structure, CAS 150322-43-3

5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-ylacetate

CAS Number150322-43-3

Synonyms5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; Prasugrel; Unii-34K66tbt99; Effient; Efient

Molecular FormulaC20H20FNO3S

Molecular Weight373.44

Purity≥98 (HPLC)%

Density1.347

Boiling Point493.5ºC at 760 mmHg

Melting Point122 °C

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9074037 Purity: ≥98 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 150322-43-3 ] Purity: ≥98 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number150322-43-3
Catalog No.2A-9074037
Chinese Name普拉格雷
Synonyms5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate; Prasugrel; Unii-34K66tbt99; Effient; Efient
Molecular FormulaC20H20FNO3S
Molecular Weight373.44
Purity≥98 (HPLC)
Density1.347
Boiling Point493.5ºC at 760 mmHg
Melting Point122 °C
Appearancepowder
Storage Condition2-8°C
ApplicationPrasugrel is an ADP receptor inhibitor that can reduce platelet aggregation by irreversibly binding to P2Y12 receptors.
PubChem ID329825336
MDL NumberMFCD09954140
SMILESCC(=O)Oc1cc2CN(CCc2s1)C(C(=O)C3CC3)c4ccccc4F
InChI1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3
InChI KeyDTGLZDAWLRGWQN-UHFFFAOYSA-N
NACRES CodeNA.77
UNSPSC12352200
BioactivityChemical & Physical Properties
Use ofPrasugrel is a platelet inhibitor with IC50 value of 1.8 μM.IC50 value:Target: P2Y12 receptorPrasugrel is a novel platelet inhibitor used for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI. Prasugrel reduces the aggregation ("clumping") of platelets by irreversibly binding to P2Y12 receptors. In rat platelets, prasugrel AM inhibited in vitro platelet aggregation induced by ADP (10 μm) with an IC50 value of 1.8 μm. From Wikipedia Properties Articles48 Biological Activity Chemical & Physical Properties
Transport InfoProduct name: Purity: 99.0%
MSDS Transport InfoModule 14. Shipping information United Nations classification: inconsistent with United Nations classification standards UN number: not specified
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA